Kura Oncology, Inc.
KURA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001422143
In the last 90 days, Kura Oncology, Inc. insiders filed 2 open-market purchases and 8 sales; 221 institutions reported holding it in 13F filings for Q2 2026, worth $953.1M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in Kura Oncology, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 183
- 0 vs. Q4 2024
- Shares held
- 80.4M
- +1.81M (+2.3%) vs. Q4 2024
- Total value
- $530.9M
- −$153.8M (−22.5%) vs. Q4 2024
- New holders
- 36
- 61 more added
- Sold out
- 36
- 57 more reduced
2 institutions that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting KURA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 221 | $953.1M |
| Q1 2026 | 222 | $686.5M |
| Q4 2025 | 215 | $888.2M |
| Q3 2025 | 200 | $742.6M |
| Q2 2025 | 182 | $473.6M |
| Q1 2025 | 183 | $530.9M |
| Q4 2024 | 185 | $686.3M |
| Q3 2024 | 179 | $1.61B |
| Q2 2024 | 174 | $1.66B |
| Q1 2024 | 165 | $1.72B |
| Q4 2023 | 141 | $1.13B |
| Q3 2023 | 133 | $686.9M |
| Q2 2023 | 148 | $795.1M |
| Q1 2023 | 141 | $885.3M |
| Q4 2022 | 142 | $870.3M |
| Q3 2022 | 148 | $977.5M |
| Q2 2022 | 148 | $1.26B |
| Q1 2022 | 152 | $1.06B |
| Q4 2021 | 151 | $897.8M |
| Q3 2021 | 152 | $1.25B |
| Q2 2021 | 171 | $1.41B |
| Q1 2021 | 171 | $1.94B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Kura Oncology, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| SEI Investments Co | 0 | $0 | 0.00% | −20,815−100.0% | Sold out |
| Blueshift Asset Management, LLC | 0 | $0 | 0.00% | −20,031−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −19,076−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −17,538−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −16,485−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,912−100.0% | Sold out |
| Bellevue Group AG | 0 | $0 | 0.00% | −13,600−100.0% | Sold out |
| Optimize Financial Inc | 0 | $0 | 0.00% | −11,447−100.0% | Sold out |
| Long Corridor Asset Management Ltd | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −7,336−100.0% | Sold out |
| Riverview Trust Co | 0 | $0 | 0.00% | −2,151−100.0% | Sold out |
| R Squared Ltd | 0 | $0 | 0.00% | −1,620−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,002−100.0% | Sold out |
| Rise Advisors, LLC | 0 | $0 | 0.00% | −531−100.0% | Sold out |
| Private Wealth Management Group, LLC | 0 | $0 | 0.00% | −243−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| Washington Trust Advisors, Inc. | 0 | $0 | 0.00% | −115−100.0% | Sold out |
| UMA Financial Services, Inc. | 0 | $0 | 0.00% | −87−100.0% | Sold out |
| IFP Advisors, Inc | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |
| Cassady Schiller Wealth Management, LLC | – | – | – | – | Not filed |